Advanced search
Search Results: 24 results for keyword "Imexpharm".
Targets being tweaked by prepared pharma
09-06-2021 20:53
There remains caution over interruption in the ingredient supply chain in Vietnam’s lucrative pharmaceutical industry, but new strategies to intensify growth potential ahead will ensure pharma groups maintain their profitability moving forward.
Imexpharm secures loan from ADB to support generic medicine production
16-12-2020 11:55
The Asian Development Bank (ADB) signed an $8 million loan with Imexpharm Corporation to help the company sustain its production of generic medicines, despite global supply disruptions caused by the COVID-19 pandemic.
SK Group acquires 25 per cent of Imexpharm
01-06-2020 14:44
South Korean conglomerate SK Group has become a large shareholder of Imexpharm (IMP), adding to its considerable portfolio of shares in Vingroup, Masan, and PV Oil.
Pharma firms expect hike in revenue thanks to COVID-19
07-04-2020 19:06
A bit of a silver lining to the COVID-19 lockdown, major pharma firms expect to see visible growth in revenue this year.
Imexpharm continues to push limits of possibility
24-02-2020 14:00
As Vietnam has become an emerging pharmaceutical market, Imexpharm is eager to invest in innovation and technology to capitalise on rising healthcare demand.
Imexpharm may scrap FOL if market winds are right
05-09-2017 17:45
Imexpharm Pharmaceutical Joint Stock Company, Vietnam's fourth-biggest pharmaceutical firm, will consider scrapping the foreign ownership limit if this becomes a common trend.
Imexpharm terminates distribution contract with IMGSA Group
29-07-2017 18:24
Imexpharm Pharmaceutical Joint Stock Company, Vietnam's fourth biggest pharmaceutical firm, will not extend the distribution contract with its foreign partner IMGSA Group in the future.
Pharmas keep foreign cap
16-05-2016 08:00
While Vietnam’s third-largest domestic drug maker Domesco has agreed to remove the foreign ownership ratio ceiling, other leading domestic pharmaceutical firms, including Imexpharm and Hau Giang Pharmaceutical JSC, have again announced no change to the cap.
Imexpharm prevails against accusations
14-05-2013 10:29
Locally-owned pharmaceutical maker Imexpharm Corporation has successfully defended itself after the Government Inspectorate accused it of violating medicine material trading regulations - but the case still damaged its reputation, company officers say.
Mobile Version